Cite
MLA Citation
Pin Zhang et al.. “Utidelone plus capecitabine versus capecitabine alone for heavily pretreated metastatic breast cancer refractory to anthracyclines and taxanes: a multicentre, open-label, superiority, phase 3, randomised controlled trial.” Lancet oncology, vol. 18, no. 3, n.d., pp. 371–383. http://access.bl.uk/ark:/81055/vdc_100045017841.0x000012